HIGGINS v. HUHTAMAKI INC

CourtDistrict Court, D. Maine
DecidedOctober 5, 2023
Docket1:21-cv-00369
StatusUnknown

This text of HIGGINS v. HUHTAMAKI INC (HIGGINS v. HUHTAMAKI INC) is published on Counsel Stack Legal Research, covering District Court, D. Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HIGGINS v. HUHTAMAKI INC, (D. Me. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MAINE LAWRENCE HIGGINS, et al., ) ) Plaintiffs ) ) v. ) 1:21-cv-00369-JCN ) HUHTAMAKI, INC., et al., ) ) Defendants ) ORDER ON MOTION TO DISMISS Plaintiffs, homeowners in Fairfield, Maine, allege Defendants, which consist of the operator of a paper mill in Waterville, Maine, and three chemical companies, are responsible for contaminating their groundwater wells and exposing them to health risks from per- and polyfluoroalkyl substances (PFAS). (Complaint, ECF No. 1-1; Third Amended Complaint, ECF No. 227.) Residual PFAS from the paper mill’s manufacturing processes were allegedly discharged into surface water, onto lands, and into the wastewater system, contaminating biosolids from the nearby water treatment facility, which biosolids were then spread as fertilizer on agricultural fields near Plaintiffs’ homes, contaminating their property and groundwater. Defendants Solenis, BASF, and 3M (collectively “Supplier Defendants”) argue that Plaintiffs have not alleged an actionable claim against them and seek dismissal pursuant to Federal Rule of Civil Procedure 12(b)(6). (Motion to Dismiss, ECF No. 237.) After consideration of the parties’ arguments and the factual allegations in the operative complaint, the Court denies the motion. BACKGROUND1 A. PFAS Characteristics and History PFAS are a group of human-made chemicals characterized by multiple fluorine

atoms bonded along a chain of carbon atoms. (See Third Amended Complaint ¶¶ 1, 27, 29.) PFAS are sometimes referred to as “forever chemicals” because they are particularly stable and break down slowly in the environment due to the strength of fluorine-carbon bonds. (Id. ¶¶ 29–30.) Because many PFAS are lipophobic and hydrophobic, they have been used in the production of certain paper and cardboard packaging since the 1950s to prevent the material from absorbing fats and water. (See id. ¶¶ 49–50.)

The Supplier Defendants manufactured and sold PFAS for commercial purposes. (Id. ¶¶ 74–76.)2 Defendant 3M pioneered the manufacture of PFAS chemicals with the development of perfluorooctanoic acid (PFOA) starting in the early 1950s. (Id. ¶ 78.) Defendant 3M conducted studies in the 1950s and early 1960s that showed its perfluorooctanesulfonate (PFOS) accumulates in the human body and is toxic. (Id. ¶ 81.)

By the 1970s, additional 3M studies revealed that its PFOS products were “even more toxic” than previously believed. (Id.) In 1999, a 3M scientist resigned in protest saying that he could “no longer participate” in a 3M process that put “markets, legal defensibility

1 The following summary is drawn from the third amended complaint and all well-pleaded facts are accepted as true for purposes of the motion to dismiss. See McKee v. Cosby, 874 F.3d 54, 59 (1st Cir. 2017). 2 Defendant Solenis International LLC, formerly Ashland Hercules Water Technology, is a corporation organized under the laws of Delaware with a principal place of business in Wilmington, Delaware. (Id. ¶ 13.) Defendant BASF is a corporation organized under the laws of New Jersey with a principal place of business in Florham Park, New Jersey. (Id. ¶ 14.) Defendant 3M is a corporation organized under the laws of Minnesota with a principal place of business in Maplewood Minnesota. (Id. ¶ 15.) and image over environmental safety” while describing PFAS as one of the most insidious chemicals in existence. (Id. ¶ 82.) In 2006, the United States Environmental Protection Agency (EPA) sanctioned Defendant 3M $1.5 million for failing to report that it had

discovered adverse health effects from PFAS. (Id. ¶ 83.) The other Supplier Defendants allegedly had similar knowledge and information about the dangers of PFAS but continued to sell the chemicals. (Id. ¶ 84.) B. The Paper Mill and PFAS Discharges Since 1999, Defendant Huhtamaki has owned and operated a paper mill in

Waterville, Maine. (Id. ¶¶ 1, 45).3 The mill has used PFAS as part of its operations since at least 1980. (Id. ¶ 46.) The manufacturing process created residuals or byproducts— mainly in the form of wastewater or sludge—containing high levels of PFAS. (Id. ¶ 51.) The PFAS remained chemically unaltered in the residuals or byproducts. (Id. ¶¶ 51, 53, 86.)

Defendant Huhtamaki disposed of the residuals or byproducts by discharge into the local sewer or discharge as surface water. (Id. ¶ 52.) The discharge ultimately became comingled with other waste in biosolids or sludge that was used as fertilizer and spread on farms. (Id. ¶¶ 52, 56, 70, 99.) Defendant Huhtamaki is the largest single contributor to the Kennebec Sanitary Treatment District plant. (Id. ¶ 57.) The PFAS-containing discharge

3 Defendant Huhtamaki, Inc., is a corporation organized under the laws of Kansas and with a principal place of business in De Soto, Kansas. (Third Amended Complaint ¶ 12.) Between 1903 and 1999, the mill was owned and operated by Keyes Fibre Company. (Id. ¶ 45.) Keyes Fibre Company was a product of at least two phases of corporate restructuring involving Rex Pulp Product Company and Arcata National Corp. (Id. ¶¶ 44–45.) contaminated the treatment plant’s sludge and/or biosolids, which were transported to fields in the region. (Id.) Once deposited on the ground or otherwise discharged into sewers or as surface waters, the PFAS migrated through the soil to groundwater and

aquifers and through runoff to nearby lands and waterways. (Id. ¶ 54–55.) The Supplier Defendants were allegedly responsible for the overwhelming majority—if not the entirety—of the sales of PFAS-containing products to Defendant Huhtamaki. (Id. ¶ 73.) The Supplier Defendants were aware of how Defendant Huhtamaki used their chemicals, and actively advised on the use of the PFAS chemicals in the paper

product manufacturing process. (Id. ¶ 85.) According to Plaintiffs, the Supplier Defendants knew that the discharges from the manufacturing process would be laden with residual PFAS. (Id. ¶ 86.) Plaintiffs also maintain that the Supplier Defendants also knew that Defendant Huhtamaki would discharge its residuals or byproducts into the sewer system, into waterways, or on the ground, and that such uncontained discharges would

almost certainly contaminate the environment, aquifers, and drinking water. (Id. ¶ 88.) Despite their knowledge that Defendant Huhtamaki’s byproducts or residuals would be highly contaminated with their PFAS products, the Supplier Defendants did not warn Defendant Huhtamaki of the hazardous nature of the contaminated byproducts or residuals. (Id. ¶ 87.)

C. Health Effects and Safety Guidelines PFAS have been categorized as endocrine disruptors and immunotoxic. (Id. ¶ 36– 37.) Health risks that have been associated with exposure to PFAS include cancer, thyroid disease, high cholesterol, ulcerative colitis, kidney disease, hypertension, obesity, gestational hypertension and preeclampsia, as well as reduced immunological functions, including decreased responsiveness to vaccines. (Id. ¶ 38–39.) Historically, water treatment systems did not test and/or filter PFAS from the water supply. (Id. ¶ 32.)

Chlorine and other disinfectants that are typically added to drinking water systems did not and do not remove PFAS chemicals from water. (Id. ¶ 33.) Due to concerns about PFAS exposure in humans and associated health risks, in June 2021, the Maine legislature required all community water systems in the state to monitor for the PFAS compounds listed by the EPA and to mitigate and continue to monitor

any well with combined PFAS levels above twenty nanograms per liter (or twenty parts per trillion). (Id. ¶ 40.) In June 2022, the EPA published health advisories for the four most common PFAS, including PFOA and PFOS. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Koken v. Black & Veatch Construction, Inc.
426 F.3d 39 (First Circuit, 2005)
Thomas v. Rhode Island
542 F.3d 944 (First Circuit, 2008)
Raymond Johnson v. H.K. Webster, Inc.
775 F.2d 1 (First Circuit, 1985)
Michael Lacey v. Joseph Arpaio
693 F.3d 896 (Ninth Circuit, 2012)
Young v. Wells Fargo Bank, N.A.
717 F.3d 224 (First Circuit, 2013)
Pottle v. Up-Right, Inc.
628 A.2d 672 (Supreme Judicial Court of Maine, 1993)
State v. Lead Industries, Ass'n, Inc.
951 A.2d 428 (Supreme Court of Rhode Island, 2008)
Charlton v. Town of Oxford
2001 ME 104 (Supreme Judicial Court of Maine, 2001)
Crowe v. Shaw
2000 ME 136 (Supreme Judicial Court of Maine, 2000)
Johnston v. ME. ENERGY RECOVERY, LTD. P'SHIP
2010 ME 52 (Supreme Judicial Court of Maine, 2010)
Cameron v. Pepin
610 A.2d 279 (Supreme Judicial Court of Maine, 1992)
In Re Lead Paint Litigation
924 A.2d 484 (Supreme Court of New Jersey, 2007)
Trusiani v. Cumberland & York Distributors, Inc.
538 A.2d 258 (Supreme Judicial Court of Maine, 1988)
Saco Steel Co. v. Saco Defense, Inc.
910 F. Supp. 803 (D. Maine, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
HIGGINS v. HUHTAMAKI INC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/higgins-v-huhtamaki-inc-med-2023.